CAYMAN CHEMICAL COMPANY Non-Antibody Products — page 1 of 2
Non-Antibody Products
Page 1,716 of 2,593
| Name | Description | Size | Catalog # | |
|---|---|---|---|---|
| N-Phenylacetyl-L-Prolylglycine ethyl ester | A synthetic dipeptide that has been shown to produce positive nootropic an… | 1 mg | 14496-1 | More Info |
| N-Phenylacetyl-L-Prolylglycine ethyl ester | A synthetic dipeptide that has been shown to produce positive nootropic an… | 10 mg | 14496-10 | More Info |
| N-Phenylacetyl-L-Prolylglycine ethyl ester | A synthetic dipeptide that has been shown to produce positive nootropic an… | 5 mg | 14496-5 | More Info |
| N-(2-phenylethyl)-Indomethacin amide | N-2PIA is one of several aromatic amides of indomethacin reported to be po… | 1 mg | 70272-1 | More Info |
| N-(2-phenylethyl)-Indomethacin amide | N-2PIA is one of several aromatic amides of indomethacin reported to be po… | 10 mg | 70272-10 | More Info |
| N-(2-phenylethyl)-Indomethacin amide | N-2PIA is one of several aromatic amides of indomethacin reported to be po… | 5 mg | 70272-5 | More Info |
| N-(2-phenylethyl)-Indomethacin amide | N-2PIA is one of several aromatic amides of indomethacin reported to be po… | 50 mg | 70272-50 | More Info |
| N-(3-Phenylpropionyl)glycine | An acylglycine; urinary levels are increased in patients with MCAD deficie… | 100 mg | 34392-100 | More Info |
| N-(3-Phenylpropionyl)glycine | An acylglycine; urinary levels are increased in patients with MCAD deficie… | 250 mg | 34392-250 | More Info |
| N-(3-Phenylpropionyl)glycine | An acylglycine; urinary levels are increased in patients with MCAD deficie… | 500 mg | 34392-500 | More Info |
| N-Phenylthiourea | A tyrosinase inhibitor (Ki = 0.21 µM in an enzyme assay using L-DOPA… | 100 g | 30855-100 | More Info |
| N-Phenylthiourea | A tyrosinase inhibitor (Ki = 0.21 µM in an enzyme assay using L-DOPA… | 25 g | 30855-25 | More Info |
| N-Phenylthiourea | A tyrosinase inhibitor (Ki = 0.21 µM in an enzyme assay using L-DOPA… | 250 g | 30855-250 | More Info |
| N-Phenylthiourea | A tyrosinase inhibitor (Ki = 0.21 µM in an enzyme assay using L-DOPA… | 50 g | 30855-50 | More Info |
| N-Piperidinyl Etonitazene (citrate) | An analytical reference standard categorized as an opioid; induces antinoc… | 1 mg | 33168-1 | More Info |
| N-Piperidinyl Etonitazene (citrate) | An analytical reference standard categorized as an opioid; induces antinoc… | 5 mg | 33168-5 | More Info |
| N-Piperidinyl 4'-hydroxy Nitazene (citrate) | An analytical reference standard that is structurally similar to known opi… | 1 mg | 37835-1 | More Info |
| N-Piperidinyl 4'-hydroxy Nitazene (citrate) | An analytical reference standard that is structurally similar to known opi… | 5 mg | 37835-5 | More Info |
| N-Piperidinyl Isotonitazene (citrate) | An analytical reference standard that is structurally similar to known opi… | 1 mg | 35106-1 | More Info |
| N-Piperidinyl Isotonitazene (citrate) | An analytical reference standard that is structurally similar to known opi… | 5 mg | 35106-5 | More Info |
| N-Piperidinyl Metonitazene (citrate) | An analytical reference standard that is structurally similar to known opi… | 1 mg | 37739-1 | More Info |
| N-Piperidinyl Metonitazene (citrate) | An analytical reference standard that is structurally similar to known opi… | 5 mg | 37739-5 | More Info |
| N-Piperidinyl Protonitazene (citrate) | An analytical reference standard that is structurally similar to known opi… | 1 mg | 37740-1 | More Info |
| N-Piperidinyl Protonitazene (citrate) | An analytical reference standard that is structurally similar to known opi… | 5 mg | 37740-5 | More Info |
| N-Pivaloylaniline | A synthetic intermediate useful for pharmaceutical synthesis. | 1 g | 10007092-1 | More Info |
CAYMAN CHEMICAL COMPANY
CAYMAN CHEMICAL COMPANY
1180 East Ellsworth Road
Ann Arbor MI 48108
P: (734) 971-3335
P: (800) 364-9897 (USA & Canada only)
F: (734) 971-3640
Customer Service: custserv@caymanchem.com
Technical Support: techserv@caymanchem.com
Sales: sales@caymanchem.com
http://www.caymanchem.com
Return to Profile